| | | | | | | |
 | VERTEX PHARMACEUTICALS | 0.98% | 2.62% | 11.88% | 32.94% | 42.30% | 82 937 |
 | REGENERON PHARMACEUTICALS, INC. | 2.99% | 4.26% | 5.13% | 24.63% | 124.44% | 81 006 |
 | WUXI APPTEC CO., LTD. | -3.21% | -1.56% | 15.12% | -11.02% | 63.55% | 40 529 |
 | BIONTECH SE | 2.08% | -2.25% | -4.53% | -16.66% | 390.96% | 34 851 |
 | BEIGENE, LTD. | -0.06% | -4.78% | 16.40% | 5.53% | 68.02% | 26 615 |
 | GENMAB A/S | 0.38% | -2.17% | -9.15% | 19.77% | 71.56% | 25 504 |
 | ARGENX SE | 0.12% | -2.69% | -0.37% | 48.10% | 166.72% | 20 898 |
 | SAREPTA THERAPEUTICS, INC. | 3.40% | -2.65% | -3.56% | 74.61% | 7.77% | 10 970 |
 | NEUROCRINE BIOSCIENCES, INC. | 2.44% | 2.09% | -7.12% | 40.38% | 10.84% | 10 664 |
 | LEGEND BIOTECH CORPORATION | 0.74% | -6.88% | 1.16% | 18.43% | --.--% | 8 454 |
 | HALOZYME THERAPEUTICS, INC. | 1.27% | 1.05% | -9.02% | 49.58% | 172.76% | 7 000 |
 | ASCENDIS PHARMA A/S | 2.72% | 1.38% | 1.60% | 2.01% | -8.16% | 6 948 |
 | KARUNA THERAPEUTICS, INC. | 2.25% | -0.76% | 1.47% | 79.53% | 110.08% | 6 852 |
 | EXELIXIS, INC. | 1.32% | 1.50% | 9.85% | -2.65% | 2.44% | 5 684 |
 | REMEGEN CO., LTD. | 3.49% | -2.27% | 12.61% | 29.11% | --.--% | 5 511 |
| | | | | | | |
| Moyenne | 1.39% | -0.87% | 2.76% | 26.29% | 94.10% | |
| Moyenne pondérée par Capi. | 1.11% | 0.33% | 5.42% | 20.86% | 108.28% | |